Medicenna Therapeutics (MDNAF) Earnings Date & Reports
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDNAF is expected to report earnings to -4 cents per share on February 12
Q4'25
Est.
$-0.04
Q3'25
Est.
$-0.05
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Est.
$-0.05
The last earnings report on November 13 showed earnings per share of -4 cents, beating the estimate of -4 cents. With 32.55K shares outstanding, the current market capitalization sits at 85.86M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDNAF showed earnings on November 13, 2025. You can read more about the earnings report here.